Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis

Molecular and Cellular Biology
Vladislav TemkinRichard M Pope

Abstract

Receptor-interacting protein (RIP) has been implicated in the induction of death receptor-mediated, nonapoptotic cell death. However, the mechanisms remain to be elucidated. Here we show that tumor necrosis factor alpha induced RIP-dependent inhibition of adenine nucleotide translocase (ANT)-conducted transport of ADP into mitochondria, which resulted in reduced ATP and necrotic cell death. The inhibition of ADP/ATP exchange coincided with the loss of interaction between ANT and cyclophilin D and the inability of ANT to adopt the cytosolic conformational state, which prevented cytochrome c release. Neither overexpression of Bcl-xL nor inhibition of reactive oxygen species prevented necrosis. In contrast, the ectopic expression of ANT or cyclophilin D was effective at preventing cell death. These observations demonstrate a novel mechanism initiated through death receptor ligation and mediated by RIP that results in the suppression of ANT activity and necrosis.

References

Jun 6, 1998·The Journal of Experimental Medicine·D VercammenP Vandenabeele
Dec 1, 1999·Cell Death and Differentiation·P G EkertD L Vaux
Aug 31, 2001·Biochemical and Biophysical Research Communications·T HatanakaH Terada
Mar 29, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·FrancesaA De GiorgiFrançois Ichas
Jun 20, 2002·Journal of Immunological Methods·Maria CastedoGuido Kroemer
Jun 22, 2002·The Journal of Biological Chemistry·Da-Ting Lin, James D Lechleiter
Nov 21, 2002·The Journal of Biological Chemistry·Tom Vanden BerghePeter Vandenabeele
Feb 5, 2003·Experimental Cell Research·Sergey Ya ProskuryakovVladimir L Gabai
Feb 26, 2003·Cell·Donald D Newmeyer, Shelagh Ferguson-Miller
Apr 30, 2003·Nature Immunology·Marja Jäättelä, Jürg Tschopp
Dec 12, 2003·The Journal of Biological Chemistry·Tom Vanden BerghePeter Vandenabeele
Jan 20, 2004·Cancer Research·Alexis Schubert, Stefan Grimm
Jan 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hongtao LiuRichard M Pope
Apr 6, 2004·Rheumatic Diseases Clinics of North America·Hongtao Liu, Richard M Pope
Jul 29, 2004·The Journal of Experimental Medicine·Marina S VivarelliRaif S Geha
Aug 3, 2004·Science·Douglas R Green, Guido Kroemer
Aug 4, 2004·The Journal of Cell Biology·Sebastian KreuzHarald Wajant
Feb 9, 2005·The Journal of Cell Biology·Xavier SaelensPeter Vandenabeele

❮ Previous
Next ❯

Citations

Jun 10, 2010·Cellular and Molecular Life Sciences : CMLS·Sreerupa Challa, Francis Ka-Ming Chan
Oct 16, 2012·Pflügers Archiv : European journal of physiology·J Marc SimardVolodymyr Gerzanich
Jan 16, 2009·Apoptosis : an International Journal on Programmed Cell Death·Oliver KeppGuido Kroemer
Jan 20, 2009·Apoptosis : an International Journal on Programmed Cell Death·Tri M TranRichard M Pope
Sep 14, 2012·Apoptosis : an International Journal on Programmed Cell Death·Denise TischnerGerhard Krumschnabel
Jul 21, 2011·Pathology Oncology Research : POR·Zsuzsanna DunaiRudolf Mihalik
Oct 11, 2008·Cell Death and Differentiation·G KroemerUNKNOWN Nomenclature Committee on Cell Death 2009
Dec 17, 2009·Cell Death and Differentiation·T Vanden BergheP Vandenabeele
Jul 21, 2012·Cell Death and Differentiation·S Jouan-LanhouetM-T Dimanche-Boitrel
May 12, 2012·Nature Reviews. Cancer·Peter Kreuzaler, Christine J Watson
Apr 17, 2008·Nature Reviews. Molecular Cell Biology·Alexei Degterev, Junying Yuan
Sep 9, 2010·Nature Reviews. Molecular Cell Biology·Peter VandenabeeleGuido Kroemer
Nov 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi KandaMasayuki Miura
Nov 30, 2011·Proceedings of the National Academy of Sciences of the United States of America·Sudan HeXiaodong Wang
Mar 16, 2011·The Journal of Experimental Medicine·Irene L Ch'enStephen M Hedrick
Sep 14, 2011·The Journal of Experimental Medicine·Emma C JosefssonBenjamin T Kile
Dec 3, 2010·Genes & Development·Junying Yuan, Guido Kroemer
Aug 6, 2013·Genes & Development·Kenta Moriwaki, Francis Ka-Ming Chan
Jun 6, 2012·Neurology Research International·Raul Chavez-ValdezFrances J Northington
Apr 28, 2012·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·M Ocker, M Höpfner
May 19, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Klitos KonstantinidisRichard N Kitsis
Mar 27, 2012·Journal of Cell Science·Stephen W G Tait, Douglas R Green
Mar 1, 2012·Molecular Medicine·Andreas LinkermannStefan Krautwald
Feb 13, 2013·International Journal of Cell Biology·Simone Fulda
Mar 4, 2010·Cellular and Molecular Life Sciences : CMLS·Franky Van HerreweghePeter Vandenabeele
May 23, 2014·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Neelakshi R Jog, Roberto Caricchio
Feb 13, 2010·Annual Review of Physiology·Russell S WhelanRichard N Kitsis
Oct 23, 2013·Molecular and Cellular Biology·Mohammad Mahabub-Uz ZamanShunsuke Ishii
May 4, 2012·Basic Research in Cardiology·Martinus I F J OerlemansJoost P G Sluijter
Feb 13, 2015·Cell Host & Microbe·Hongyan GuoEdward S Mocarski
Oct 4, 2011·Critical Reviews in Oncology/hematology·Wei WuJianyong Li
Mar 30, 2010·Trends in Biochemical Sciences·David Moquin, Francis Ka-Ming Chan
Feb 5, 2008·Clinics in Liver Disease·George E N Kass, Shirley C Price

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.